Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 12, 2007, Pages 1294-1299

  Santos, Ronaldo V T ^a,b   Batista Jr , Miguel L ^a   Caperuto, Érico C ^a   Costa Rosa, Luis F B P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adriamycin; Cellular damage; Creatine; Injury; Vitamin C; Vitamin E

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ASCORBIC ACID; CREATININE; DOXORUBICIN; LACTATE DEHYDROGENASE; SODIUM CHLORIDE; UREA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; RAT; SURVIVAL; VITAMIN SUPPLEMENTATION; WEIGHT REDUCTION;

ALANINE TRANSAMINASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ASCORBIC ACID; CREATINE; CREATININE; DOXORUBICIN; DRUG THERAPY, COMBINATION; L-LACTATE DEHYDROGENASE; MALE; PROTECTIVE AGENTS; RATS; RATS, WISTAR; SURVIVAL RATE; UREA; VITAMIN E; VITAMINS; WEIGHT LOSS;

EID: 35548970387     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04717.x     Document Type: Article

References (38)

1. Singal P, Li T, Kumar D et al. Adriamycin-induced heart failure: Mechanism and modulation. Mol. Cel. Biochem. 2000 207 : 77 85.
2. Li T, Singal PK. Adriamycin-induced early changes in myocardial antioxidant enzymes and their modulation by probucol. Circulation 2000 102 : 2105 10.
3. Singal PW, Tong J. Vitamin E deficiency accentuates adriamycin-induced cardiomyopathy and cell surface changes. Mol. Cell. Biochem. 1998 84 : 163 71.
4. Liu X, Chua CC, Younberg GA et al. Melatotin as an effective protector against doxorubicin-induced cardiotoxity. Am. J. Physiol. Heart Circ. Physiol. 2002 283 : H254 63.
5. Lou H, Danelisen I, Singal PK. Cytokines are not up regulated in adriamycin-induced cardiomyopathy and heart failure. J. Mol. Cell. Cardiol. 2004 36 : 683 90.
6. Shimpo K, Nagatsu T, Yamada K et al. Ascorbic acid and adriamycin toxicity. Am. J. Clin. Nutr. 1991 54 (Suppl S1298 301.
7. Agapito MT, Antolinn Y, Del Brio MT et al. Protective effect of melatonin against adriamycin toxicity in the rat. J. Pineal Res. 2001 31 : 23 30.
8. Cao Y, Kennedy R, Klimberg S. Glutamine protects against doxorubicin-induced cardiotoxicity. J. Surg. Res. 1999 85 : 178 82.
9. Xu MF, Ho S, Qian ZM et al. Melatonin protects against cardiac toxicity of doxorubicin in rat. J. Pineal Res. 2001 31 : 301 7.
10. Doroshoow JH, Tallent C, Schechter JE. Ultrastructural features of adriamycin-induced skeletal and cardiac muscle toxicity. Am. J. Pathol. 1985 118 : 228 97.
11. Venkatesan N, Punithavathi D, Arumugan V. Curcumin prevents adriamycin nephrotoxicity in rats. Br. J. Pharmacol. 2000 129 : 231 4.
12. Mohamed HE, El-Swefy S, Hagar HH. The protective effect of glutathione administration on adriamycin-induced acute cardiac toxicity in rats. Pharmacol. Res. 2000 42 : 115 20.
13. Odom AL, Hatwig CA, Stanley JS et al. Biochemical determinants of adriamycin toxicity in mouse liver, heart and intestine. Biochem. Pharmacol. 1992 43 : 831 6.
14. Bordoni A, Biagi P, Hrelia S. The impairment of essential fatty acid metabolism as a key factor in doxorubicin-induced damage in cultured rat ardiomyocytes. Biochem. Biophys. Acta 1999 25 : 100 6.
15. Siveski-Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 1994 89 : 2829 35.
16. Tokarska-Schlattner M, Wallimann T, Schlattner U. Multiple interference of anthracyclines with mitochondrial creatine kinases: Preferential damage of the cardiac isoenzyme and its implications for drug cardiotoxicity. Mol. Pharmacol. 2002 61 : 516 23.
17. Thomas CE, Aust. SD. Reductive release of iron from ferritin by cation free radicals of paraquat and other bipyridyls. J. Biol. Chem. 1996 261 : 13 064 70.
18. Kalender Y, Yel M, Kalender S. Doxorubicin hepatotoxicity and hepatic free radical metabolism n rats. The effects of vitamin E and catechin. Toxicology 2005 206 : 39 45.
19. Quiles JL, Huertas JR, Battino M et al. Antioxidant nutrients and adriamycin toxicity. Toxicology 2002 180 : 79 95.
20. Berthiame JM, Oliveira PJ, Fariss MW et al. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial function. Cardiovasc. Toxicol. 2005 5 : 257 67.
21. Carr AC, Fgrei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am. J. Clin. Nutr. 1999 69 : 1086 107.
22. Lawler JM, Barnes WS, Wu G et al. Direct antioxidant properties of creatine. Biochem. Biophys. Res. Commun. 2002 290 : 47 52.
23. Op 't Eijnde B, Richeter EA, Henquin JC, Kiens B, Hespel P. Effect of creatine supplementation on creatine and glycogen content in rat skeletal muscle. Acta Physiol. Scand. 2001 171 : 169 76.
24. Nelson AG, Arnall DA, Kokkonen J et al. Muscle glycogen supercompensation is enhance by prior creatine supplementation. Med. Sci. Sports Exerc. 2001 33 : 1096 100.
25. Horn M, Remkes H, Dienesch C et al. Chronic high-dose creatine feeding does not attenuate left ventricular remodeling in rat hearts post-myocardial infarction. Cardiovasc. Res. 1999 43 : 117 24.
26. Schilling BK, Stone MH, Utter A et al. Creatine supplementation and health variables: A retrospective study. Med. Sci. Sports Exerc. 2001 33 : 183 8.
27. Andrews R, Greenhaft P, Curtis S et al. The effect of dietary creatine supplementation on skeletal muscle metabolism in congestive heart failure. Eur. Heart J. 1998 19 : 617 22.
28. Zammit VA, Nelsholme EA. The maximum activities of hexokinase, phosphorylase, phosphofructokinase, glycerol phosphate dehydrogenases, lactate dehydrogenase, octopine dehydrogenase, phosphoenolpiruvate carboxykinase, nucleoside diphosphatekinase, glutamate-oxaoloacetate transaminase and arginine kinase in relations to carbohydrate utilization in muscle from marine invertebrates. Biochem. J. 1976 160 : 447 62.
29. Granzotto M, Rapozzi V, Decorti G et al. Effects of melatonin on doxorubicin cytotoxicity in sensitive and pleiotropically resistant tumor cells. J. Pineal Res. 2001 31 : 206 21.
30. Wapstra FH, Van Goor H, De Jong PE et al. Dose of doxorubicin determines severity of renal damage and responsiveness to ACE-inhibition in experimental nephrosis. J. Pharmacol. Toxicol. 1999 41 : 69 73.
31. Saad S, Najjar TA, Al-Rikabi A. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol. Res. 2001 43 : 211 18.
32. Yilmaz S, Atessahin A, Sahna E et al. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology 2006 218 : 164 71.
33. Oz E, Erbas D, Surucu HS et al. Prevention of doxorubicin-induced cardiotoxicity by melatonin. Mol. Cell. Biochem. 2006 282 : 31 7.
34. Oz E, Ilhan MN. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol. Cell. Biochem. 2006 286 : 11 15.
35. Kurabayashi M, Jeyaseelan R, Kedes L. Doxorubicin represses the function of the myogenic helix-loop-helix transcription factor MyoD. Involvement of Id gene induction. J. Biol. Chem. 1994 269 : 6031 9.
36. Stathopoulos GP, Papadopoulos NG, Stephanopoulou A et al. An increase of serum lipids after cumulative doses of doxorubicin and epirubicin in experimental animals. Anticancer Res. 1996 16 : 3429 33.
37. Zima T, Tesar V, Richardson PJ et al. Effects of doxorubicin (adriamycin) and [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)]propane (ICRF-187) on skeletal muscle protease activities. Toxicol. Appl. Pharmacol. 2001 171 : 135 40.
38. Puri A, Maulik SK, Ray R et al. Electrocardiographic and biochemical evidence for the cardioprotective effect of vitamin E in doxorubicin-induced acute cardiotoxicity in rats. Eur. J. Pediatr. Surg. 2005 15 : 387 91.